Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10,138 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Corticosteroids in COVID-19 and non-COVID-19 ARDS: a systematic review and meta-analysis.
Chaudhuri D, Sasaki K, Karkar A, Sharif S, Lewis K, Mammen MJ, Alexander P, Ye Z, Lozano LEC, Munch MW, Perner A, Du B, Mbuagbaw L, Alhazzani W, Pastores SM, Marshall J, Lamontagne F, Annane D, Meduri GU, Rochwerg B. Chaudhuri D, et al. Among authors: ye z. Intensive Care Med. 2021 May;47(5):521-537. doi: 10.1007/s00134-021-06394-2. Epub 2021 Apr 19. Intensive Care Med. 2021. PMID: 33876268 Free PMC article.
Treatment of patients with nonsevere and severe coronavirus disease 2019: an evidence-based guideline.
Ye Z, Rochwerg B, Wang Y, Adhikari NK, Murthy S, Lamontagne F, Fowler RA, Qiu H, Wei L, Sang L, Loeb M, Shen N, Huang M, Jiang Z, Arabi YM, Colunga-Lozano LE, Jiang L, Koh Y, Liu D, Liu F, Phua J, Shen A, Huo T, Du B, Zhai S, Guyatt GH. Ye Z, et al. CMAJ. 2020 May 19;192(20):E536-E545. doi: 10.1503/cmaj.200648. Epub 2020 Apr 29. CMAJ. 2020. PMID: 32350002 Free PMC article. No abstract available.
Efficacy and safety of corticosteroids in COVID-19 based on evidence for COVID-19, other coronavirus infections, influenza, community-acquired pneumonia and acute respiratory distress syndrome: a systematic review and meta-analysis.
Ye Z, Wang Y, Colunga-Lozano LE, Prasad M, Tangamornsuksan W, Rochwerg B, Yao L, Motaghi S, Couban RJ, Ghadimi M, Bala MM, Gomaa H, Fang F, Xiao Y, Guyatt GH. Ye Z, et al. CMAJ. 2020 Jul 6;192(27):E756-E767. doi: 10.1503/cmaj.200645. Epub 2020 May 14. CMAJ. 2020. PMID: 32409522 Free PMC article.
Efficacy and safety of antiviral treatment for COVID-19 from evidence in studies of SARS-CoV-2 and other acute viral infections: a systematic review and meta-analysis.
Liu W, Zhou P, Chen K, Ye Z, Liu F, Li X, He N, Wu Z, Zhang Q, Gong X, Tang Q, Du X, Ying Y, Xu X, Zhang Y, Liu J, Li Y, Shen N, Couban RJ, Ibrahim QI, Guyatt G, Zhai S. Liu W, et al. Among authors: ye z. CMAJ. 2020 Jul 6;192(27):E734-E744. doi: 10.1503/cmaj.200647. Epub 2020 Jun 3. CMAJ. 2020. PMID: 32493740 Free PMC article.
Remdesivir for severe covid-19: a clinical practice guideline.
Rochwerg B, Agarwal A, Zeng L, Leo YS, Appiah JA, Agoritsas T, Bartoszko J, Brignardello-Petersen R, Ergan B, Ge L, Geduld H, Gershengorn HB, Manai H, Huang M, Lamontagne F, Kanda S, Kawano-Dourado L, Kurian L, Kwizera A, Murthy S, Qadir N, Siemieniuk R, Silvestre MA, Vandvik PO, Ye Z, Zeraatkar D, Guyatt G. Rochwerg B, et al. Among authors: ye z. BMJ. 2020 Jul 30;370:m2924. doi: 10.1136/bmj.m2924. BMJ. 2020. PMID: 32732352
Traitement des patients atteints d’une forme modérée ou grave de maladie à coronavirus 2019: Ligne directrice fondée sur des données probantes.
Ye Z, Rochwerg B, Wang Y, Adhikari NK, Murthy S, Lamontagne F, Fowler RA, Qiu H, Wei L, Sang L, Loeb M, Shen N, Huang M, Jiang Z, Arabi YM, Colunga-Lozano LE, Jiang L, Koh Y, Liu D, Liu F, Phua J, Shen A, Huo T, Du B, Zhai S, Guyatt GH. Ye Z, et al. CMAJ. 2020 Oct 26;192(43):E1323-E1333. doi: 10.1503/cmaj.200648-f. CMAJ. 2020. PMID: 33106308 Free PMC article. French. No abstract available.
10,138 results
You have reached the last available page of results. Please see the User Guide for more information.